Recorded lectures

Aim

To provide an update on the current evidence base relating to the self management of chronic pain.

Learning outcomes

Learning Outcomes

• Define pain
• Differentiate between acute and chronic pain
• Understand the consequences of chronic pain
• Recognise the value of goal setting for patients living with chronic pain
• Understand the concept of pacing and spacing activities
• List pain self management programmes available

Aim

To optimise the use of insulins in practice.

Learning outcomes

Intended Learning outcomes:

• Understand the mode of action for different types of insulins
• Appreciate the indications for the use of these products in practice
• Highlight the key safety issues associated with the different types of insulins
• Implement strategies to improve the safe use of insulins within your patient population.

Tutors

• Mrs Roisin Murphy
  Clinical Pharmacist, SHSCT.
• Ms Sinead Doyle
  Clinical Pharmacist, SHSCT.

Aim

To optimise the use of direct-acting oral anticoagulants (DOACs) in practice.

Learning outcomes

Intended Learning outcomes:

• Understand the mode of action for the DOACs
• Appreciate the indications and range of dosing schedules available for these drugs
• Identify drugs that interact with the DOACs and the effects of such interactions
• Highlight the key safety issues associated with the DOACs
• Implement strategies to improve the safe use of DOACs within your patient population.

Tutors

• Ms Jenny Kirkwood
  
• Ms Mary McBride
  Pharmacy Advisor, SPPG
• Ms Clare Stevenson
  Speech and Language Therapist and Dysphagia Coordinator SEHSCT

Aim

To provide an overview of best practice in assessing dysphagia in adult patients including the implementation of the IDSSI descriptors and how they relate to medication options This programme will be delivered over two evenings. Part 2 will be held on Wednesday 28th September and Thursday 20th October.

Learning outcomes

Intended learning outcomes:

• Regional update on the work of Dysphagia NI
• Identify eating, drinking and swallowing difficulties
• Assess patients with swallowing difficulties, decide when Speech and Language therapy should be involved, and on whose advice should medications be changed from solid dosage forms
• Outline IDDSI descriptors and how thickeners may be used within different descriptor levels
• Utilise a stepwise approach to medication selection for patients with eating, drinking and swallowing difficulties, whilst signposting to resources to assist with this.

Tutors

• Ms Clare Stevenson
  Speech and Language Therapist and Dysphagia Coordinator SEHSCT
• Ms Mary McBride
  Pharmacy Advisor, SPPG
• Ms Carolee McLaughlin
  

Aim

To provide an overview of the DAMES project, as an example of a Quality Improvement project, accompanied by reflection and discussion of learnings from previous Serious Adverse Incidents to reduce the risk of further choking events, through multidisciplinary collaborative working.

Learning outcomes

Intended learning outcomes:

• Provide an overview of Dames, as an example of quality improvement projects supporting medication use for people with eating, drinking, swallowing difficulties
• Utilise learnings from local serious adverse incidents to reduce patient harm
• Multidisciplinary discussion regarding reducing the risk of further choking events through improved communication pathways.

Tutors

• Mrs Aine Liggett
  Northern Ireland Medicines and Poisons Advice Service
• Ms Siobhan Kelly
  Lead Nurse for Yellow Card Centre Northern Ireland

Aim

To promote the importance of healthcare professionals reporting adverse events to the MHRA’s Yellow Card scheme to improve patient safety.

Learning outcomes

Having completed this webinar you will be able to:

• Describe the role of the NI Yellow Card Centre
• Understand the benefits of reporting via the Yellow Card scheme
• List the range of products for which safety issues should be reported
• Define the information to be reported within a Yellow Card report
• Report relevant adverse events within your professional practice.

Tutors

• Ms Joy Watson
  Addictions Consultant, BHSCT
• Ms Mary McBride
  Pharmacy Advisor, SPPG
• Ms Lisa Byers
  Controlled Drugs DoH (CDAO)
• Ms Caren Walsh
  General Practitioner, Medical Adviser SPPG and QI Lead Primary Care
• Ms Emma McDowell
  Lead pharmacist for Pain Management Deprescribing, NHSCT

Aim

To provide a discussion forum exploring the misuse / dependence of Gabapentinoids in society.

Learning outcomes

Having completed this webinar, you will be able to:

• Define the terms misuse and dependence
• Recognise the risks associated with Gabapentinoids use and the signs of misuse and dependence
• Consider reduction strategies to help prevent / reduce the abuse of Gabapentinoids in primary care settings
• Provide support to patients who have developed issues of dependence when using Gabapentinoids
• Share your knowledge with colleagues to promote the safe and effective supply and use of Gabapentinoids in practice.

Tutors

• Dr Noel Crockett
  Acting Consultant / Speciality Doctor in Psychiatry, WHSCT
• Mrs Michelle McCourt
  Medicines Management Adviser, HSCB.

Aim

To provide an overview of the management of depression (including the new NICE guideline) and to consider hypnotic and anxiolytic prescribing in primary care.

Learning outcomes

Having completed this webinar, you will be able to:

• Advise on the management of depression in adults
• Consider non-pharmacological options
• List the choices of antidepressants
• Recognise the harms associated with hypnotics and anxiolytics
• Make recommendations on how to reduce or stop hypnotics and anxiolytics

Tutors

• Ms Lisa Byers
  Controlled Drugs DoH (CDAO)
• Ms Joy Watson
  Addictions Consultant, BHSCT
• Mr Canice Ward
  Head of Medicines Regulatory Group, Department of Health
• Dr Carolyn Adgey
  Consultant Gastroenterologist, BHSCT

Aim

To provide a discussion forum to explore the potential misuse of OTC opioid products. Specifically, to recognise the signs and symptoms of their misuse, discuss and explore strategies to manage the supply of these medicines in the community pharmacy setting and provide support to patients who have developed problems with these products.

Learning outcomes

Having completed this webinar, you will be able to:

• Define the terms misuse and dependence
• Recognise signs of opioid misuse and dependence
• Consider strategies to help prevent/reduce the abuse of opioid products in a community pharmacy setting
• Discuss the risks of potential misuse/dependence with patients
• Share your knowledge with your pharmacy team to ensure safe and effective supply of OTC opioid products.